Form 4: Balchem EVP Miyata Reports Equity Transactions

Balchem Corporation's EVP, CLO, and Secretary, Hatsuki Miyata, reported the acquisition of restricted stock and performance units, alongside the disposition of shares for tax withholding.

Summary

• Hatsuki Miyata, EVP, CLO, and Secretary of Balchem Corporation, reported multiple equity transactions on February 11 and 12, 2026.
• Acquired 1,710 shares of common stock through restricted stock vesting, with ownership vesting over a three-year period (25% on the first anniversary, 25% on the second, and 50% on the third anniversary of the grant date).
• Acquired 2,247 shares of common stock from the vesting of performance stock units for the 2023-2025 performance period, including 37 dividend equivalent shares.
• Disposed of 877 shares of common stock at a price of $178.68 to cover tax requirements upon the vesting of performance stock units.
• Disposed of 181 shares of common stock at a price of $177.49 to cover withholding taxes upon the vesting of restricted shares granted on February 12, 2025.
• Acquired 6,300 stock options with an exercise price of $178.68, vesting over three years (20% Year 1, 40% Year 2, and 40% Year 3) and expiring on February 11, 2036.
• Following these transactions, Hatsuki Miyata directly beneficially owns 8,745 shares of common stock and 6,300 stock options, in addition to 487 shares indirectly owned through a 401(k) Plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event for the executive, reflecting the successful vesting of equity awards and the grant of new options, indicating continued alignment with company performance. The tax-related dispositions are standard and not indicative of negative sentiment.

Positives

• Acquisition of 1,710 shares of common stock through restricted stock vesting, increasing direct ownership.
• Acquisition of 2,247 shares of common stock from the vesting of performance stock units, reflecting achievement of performance targets for the 2023-2025 period.
• Grant of 6,300 stock options with an exercise price of $178.68, providing future equity upside potential and aligning executive incentives with long-term shareholder value.

Negatives

• Disposition of 877 shares at $178.68 to cover tax obligations upon vesting of performance stock units.
• Disposition of 181 shares at $177.49 to cover withholding taxes upon vesting of restricted shares.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that these transactions are routine executive compensation events, common across publicly traded companies, and do not reflect broader industry trends or specific competitive dynamics. They are part of standard long-term incentive plans designed to align executive interests with shareholder value.

Comparison to Industry Standards

• These equity compensation grants and vestings are consistent with typical executive incentive structures observed in the specialty chemicals and nutrition industries.
• Companies like International Flavors & Fragrances (IFF) or Kerry Group often utilize a mix of restricted stock, performance units, and stock options to reward and retain key executives.
• The vesting schedules and tax withholdings detailed in the filing are standard practices for executive equity compensation across comparable industry players.

Stakeholder Impact

• Shareholders: The vesting of performance units suggests the company met certain performance targets, which is generally positive for shareholders. The grant of options aligns executive incentives with long-term shareholder value creation.
• Employees: These transactions are specific to a senior executive and do not directly impact the broader employee base, though they reflect the company's overall compensation philosophy.

Next Steps

• Continued vesting of restricted stock over the next three years (25% on first anniversary, 25% on second, 50% on third anniversary of grant date).
• Continued vesting of stock options over the next three years (20% Year 1, 40% Year 2, and 40% Year 3).

Key Dates

Recommendation

This Form 4 filing details routine executive compensation transactions (vesting of equity awards and grant of options) and tax-related share dispositions. While it indicates continued executive alignment with company performance, it does not provide new material information about the company's operational or financial health that would warrant a change in investment recommendation. It's a standard disclosure of insider activity.

Keywords

Balchem Corporation, BCPC, Hatsuki Miyata, Form 4, insider trading, beneficial ownership, restricted stock, performance stock units, stock options, equity compensation, executive compensation